100 related articles for article (PubMed ID: 1294595)
21. Immunoscintigraphy in intraocular malignant melanoma.
Scheidhauer K; Markl A; Leinsinger G; Moser E; Scheiffarth OF; Riedel KG; Schaal TS; Stefani FH; Schumacher U
Nucl Med Commun; 1988 Sep; 9(9):669-78. PubMed ID: 3263596
[TBL] [Abstract][Full Text] [Related]
22. Color flow mapping: a non-invasive tool for characterizing and differentiating between uveal melanomas and choroidal metastases.
Neudorfer M; Waisbourd M; Anteby I; Liran A; Goldenberg D; Barak A; Kessler A
Oncol Rep; 2011 Jan; 25(1):91-6. PubMed ID: 21109962
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of ocular melanoma immunoscintigraphy.
Janković Z; Pucar D; Jauković L; Ajdinović B
J BUON; 2006; 11(3):347-50. PubMed ID: 17309161
[TBL] [Abstract][Full Text] [Related]
24. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.
Blend MJ; Ronan SG; Salk DJ; Gupta TK
J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923
[TBL] [Abstract][Full Text] [Related]
25. Primary malignant melanoma arising in an ovarian dermoid cyst: proposed use of radioimmunoscintigraphy with 99mTc-F(ab')2 antimelanoma antibody for staging and follow-up. Case report.
Di Vagno G; Mele M; Resta L; Maiorano E; Loverro G; Salzillo F; Masotina A; Selvaggi L; D'Addabbo A
Eur J Gynaecol Oncol; 1993; 14(3):237-45. PubMed ID: 8508882
[TBL] [Abstract][Full Text] [Related]
26. Role of radioimmunoscintigraphy and SPET in the diagnosis of patients with malignant melanoma.
Sergieva S; Goranov K; Piperkova E; Tzingilev D; Trojanova P; Peitcheva E; Kulkin V
Nucl Med Commun; 1994 Mar; 15(3):168-72. PubMed ID: 8190407
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
28. Immunoscintigraphy with anti-225.28S for ocular melanoma--a comparison with histology and immunohistochemistry.
Bräutigam P; Loeffler KU; Krause T; Högerle S; Simon J; Moser E
Nuklearmedizin; 1997 Mar; 36(2):42-6. PubMed ID: 9090646
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of (123)N-isopropyl-p-[(123)I]-iodoamphetamine single photon emission computed tomography for the diagnosis of uveal malignant melanoma.
Goto H; Usui M; Ishii I
Am J Ophthalmol; 2001 Dec; 132(6):937-9. PubMed ID: 11730669
[TBL] [Abstract][Full Text] [Related]
30. Ocular radioimmunoscintigraphy: sensitivity and practical considerations.
Bomanji J; Nimmon CC; Hungerford JL; Solanki K; Granowska M; Britton KE
J Nucl Med; 1988 Jun; 29(6):1031-7. PubMed ID: 3373313
[TBL] [Abstract][Full Text] [Related]
31. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro detection of dopamine d2 receptors in uveal melanomas.
Bodei L; Hofland LJ; Ferone D; Mooy CM; Kros JM; Paridaens DA; Baarsma SG; Ferdeghini M; Van Hagen MP; Krenning EP; Kwekkeboom DJ
Cancer Biother Radiopharm; 2003 Dec; 18(6):895-902. PubMed ID: 14969602
[TBL] [Abstract][Full Text] [Related]
33. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
Everaert H; Bossuyt A; Flamen P; Mertens J; Franken PR
J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
[TBL] [Abstract][Full Text] [Related]
34. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H
Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802
[TBL] [Abstract][Full Text] [Related]
35. CT-scan and intraocular tumours: detection and assessment of size and extrascleral growth of uveal melanomas.
de Keizer RJ; Vielvoye GJ; de Wolff-Rouendaal D
Doc Ophthalmol; 1986 Jan; 61(3-4):285-94. PubMed ID: 3512218
[TBL] [Abstract][Full Text] [Related]
36. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
[TBL] [Abstract][Full Text] [Related]
37. Pseudomelanomas of the posterior uveal tract: the 2006 Taylor R. Smith Lecture.
Shields JA; Mashayekhi A; Ra S; Shields CL
Retina; 2005 Sep; 25(6):767-71. PubMed ID: 16141866
[TBL] [Abstract][Full Text] [Related]
38. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
39. Uptake of 99mTc labelled (Fab')2 fragments of monoclonal antibody 225.28S by a benign ocular naevus.
Bomanji J; Hungerford JL; Granowska M; Britton KE
Eur J Nucl Med; 1988; 14(3):165-6. PubMed ID: 3402506
[TBL] [Abstract][Full Text] [Related]
40. [Immunoscintigraphy of choroid melanoma using monoclonal antibodies].
Schaling DF; van Kroonenburgh MJ; Borsje RA; Kakebeeke-Kemme HM; Oosterhuis JA; Pauwels EK
Ned Tijdschr Geneeskd; 1989 Aug; 133(33):1644-7. PubMed ID: 2797273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
